Tesamorelin is a synthetic analog of human GHRH(1-44) with a trans-3-hexenoyl group attached to the N-terminal tyrosine. The lipid modification confers resistance to dipeptidyl peptidase-IV cleavage, extending its functional half-life relative to native GHRH.
Each vial is lyophilized from acetate buffer, sealed under nitrogen, and shipped ~4 days from our lab.
Sold for laboratory research only. This material is not a drug, food, or cosmetic and is not intended for diagnostic, therapeutic, or recreational use.
Identity
Parameter
Value
Sequence
trans-3-hexenoyl-Tyr¹-hGHRH(1-44)
Molecular formula
C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular weight
5135.86 g/mol
CAS number
901758-09-6
Length
44 residues
Quality
Test
Specification
HPLC purity
99.04%
Lot LM-2715 (10 mg)
Independently tested by Testides (report LUME-TESA-10-061626): HPLC-UV purity and peptide content for the 10 mg lot. COAs for other strengths are available on request: email support@lumerapeptide.com with your batch number.
Allow vial to reach room temperature before opening (≥ 20 minutes). Reconstitute with 1.0-2.5 mL of sterile bacteriostatic water (0.9% benzyl alcohol). Inject solvent slowly down the inner wall of the vial; do not direct stream onto the lyophilized cake.
Swirl gently for 30 seconds. Do not vortex. Allow to dissolve for 5 minutes; clarity should be complete with no visible particulates.
Storage after reconstitution
Reconstituted solution is stable for 28 days at 2-8 °C in original vial. For longer storage, aliquot into low-binding tubes and hold at −80 °C; avoid repeated freeze-thaw cycles. Discard if turbidity, color change, or particulate matter is observed.
